envometinib
Generic: IMM-6-415·Code: IMM-6-415
envometinib: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Immuneering Corp (IMRX) | Phase 1/Phase 2 |
Get deeper analysis on envometinib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis